New Hope Network’s Natural Products Expo West, scheduled for 3-7 March in Anaheim, CA, postponed due to the coronavirus (Covid-19), but the group announced 3 March that it expects to schedule another date for the event by mid-April, either in Anaheim or a suitable alternative. “As with all our events, it was the intention here at Expo West in Anaheim, to follow official guidance from local authorities and to listen to the voices of the community we serve and support, in order to maximize the health of the industry. Today it is clear the majority of those voices are saying they want Expo West but not this week,” New Hope Network Fred Linder said in the release. New Hope, which is owned by HBW Insight publisher Informa Inc., said it plans to work with all exhibitors and attendees on credits and support, “with particular focus on the many entrepreneurs and small businesses who are the heartbeat of this community, for whom we are going to stand up a rebate fund of $5m targeted at their specific needs.” The company continues planning to conduct Natural Products Expo East, 23-26 September in Philadelphia.
HBW Market Roundup: Expo West Postponed, FDA Needs International Cosmetics Meeting Input, More
New Hope Network postponed Natural Products Expo West trade show due to coronavirus; NPA supports Accurate Labels Act; American Health Packaging recalls OTC ranitidine; and FDA seeks input on topics for upcoming International Cooperation on Cosmetics Regulation meeting.
More from Ingredients & Safety
Reclassifying ethanol as a carcinogenic, mutagenic, or reprotoxic substance - something the European Chemicals Agency seems likely to do in the near future - would be “tantamount to a de facto ban” with “fatal consequences” for medical care in Germany, says Pharma Deutschland in a joint paper with 13 other German healthcare industry associations.
Two AESGP papers reviewing the evidence for AMR risk associated with a range of OTC antifungals and antivirals conclude there is litte to no risk associated with the responsible self-care use of such medicines.
“Protecting the environment is a shared responsibility. It is unfair to expect only two sectors to fund wastewater treatment modernization and operation,” argues AESGP director general Jurate Švarcaite.
Supplements already under close scrutiny in the EU have been linked to severe adverse effects on the musculoskeletal system and liver, even at low doses.
More from HBW Insight
Two nail care ingredients included in the European Commission’s Omnibus VII, which includes about two dozen ingredients overall, are banned in Europe in September.
A round-up of the latest European health & wellness market moves: Maxwellia names chief operating officer; Nestle appoints marketing & sales head; Alland & Robert gets deputy general manager.
US businesses across industry sectors remain apprehensive about higher tariffs going into effect on imports from China after three-month pause allowed on other changes.